Bryan D. Choi MD PhD
@BryanDChoi
Followers
3K
Following
495
Media
36
Statuses
223
Neurosurgeon and Scientist, Massachusetts General Hospital
Boston, MA
Joined July 2017
Seeking stellar students, postdocs and scientists interested in making a difference in #braintumor and #immunotherapy, #CARTcell. Kicking off my lab @mghneurosurg. Please share or reach out for more info!
5
44
216
Beautiful day for the Mass General Brigham Eversource Cancer 5K Run-Walk to support Brian’s Fund and cancer care! Thanks to all our participants and donors! @MGHCancerCenter @BryanDChoi @ShankarLabMGH @MGBneurosurgery
0
4
10
A major win for solid tumors; GD2 #CART mediated a 40% complete remission rate in children with high-risk neuroblastoma @NatureMedicine ! https://t.co/glLilR2b1g
nature.com
Nature Medicine - In the final analysis of a phase 1/phase 2 trial of autologous GD2-targeting CAR T cells in pediatric patients with high-risk metastatic, relapsed or refractory neuroblastoma,...
4
18
91
Great discussion on surgical ventricular entry in Glioma @CNS_Update podcast with @BryanDChoi @KimberlyBHoang and @gecicinn thanks for the invitation!
The September Journal Club Podcast is out now! Listen to our latest episode on ventricular entry during Glioblastoma resection and the associated risks and survival rate and hear from the authors Neslihan Gecici and Pascal Zinn on their research. Tune in wherever you get your
2
9
27
Thank you to visiting professor @BryanDChoi for the insightful Grand Rounds talk on "CAR T for Glioma, from Bench to Bedside." Choi is an associate professor of neurosurgery at @harvardmed @MGBneurosurgery.
1
7
45
It was amazing today to visit the @MGHCancerCenter to meet with Dr. Choi and Dr. Grewal and to walk through the labs that are the recipient of A Shot For Life funding! We certainly know this as an organization, but we hope that all in our community are aware of just how
0
6
28
Congrats @rishabrama and collaborators @MGBneurosurgery on our work developing Meso-CAR T cells for refractory meningiomas, published this week @NeuroOnc! https://t.co/uBr2cXlcup
3
22
119
My son David with the talented Rishab Ramapriyan @rishabrama, (soon to be a @PennNSG resident) in my early career @MGHNeurosurg lab space, but now the home of the @BryanDChoi lab. David is working on the same CAR-T cell approach for glioma that I studied in my post-doc years as a
8
8
163
"Defying death two years after brain cancer diagnosis..." Check out this piece by @angRchen on recent advances reported from our group and others at #ASCO25
https://t.co/YHC6E3SPJs via @statnews
statnews.com
ASCO heard data suggesting that cell therapy may be a way of treating glioblastoma, which has been long seen as incurable.
0
0
13
In GBM, where survival is measured in months, remission beyond 2 years is extraordinary. CAR-T @ASCO updates: 👉 @BryanDChoi @MGBneurosurgery 👉 @DrORourke2 @StephenBagleyMD @PennCancer show tumor shrinkage, extended survival, and real signs of durability. Let's Build!
2
9
53
Congrats @StephenBagleyMD @DrORourke2 and colleagues @PennCancer on their manuscript in @NatureMedicine showing safety and early efficacy of bivalent CAR T cells in 18 patients with recurrent #glioblastoma! https://t.co/n2QewBy7MZ
3
33
155
Thank you Dr. Jim Rutka for your phenomenal leadership as the Editor-in-Chief of the @thejnspg! We celebrate your hard work & contributions from 2013-2025 & welcome Dr. Fred Barker of the @MGBneurosurgery. The Journal is in great hands for years to come! https://t.co/ySHorNyJvo
4
8
65
Thank you, @NREFORG! Grateful for the medical student fellowship I received last year, which supported my preclinical brain tumor #CART cell therapy research with @BryanDChoi. Encourage all interested med students to apply for @NREFORG funding in the next cycle.
Check out our latest post on Instagram! - https://t.co/uD3Yy91IG7 Big congrats to NREF Medical Student Summer Research Fellowship grant awardee, @rishabrama, on matching at @PennNSG! @MGBneurosurgery
1
3
13
Brian Nahed, MD, Amy Maguire, MS, and the MGB Neurosurgical, SLP and Intraopertative Neuromonitoring teams have received funding from an SBIR grant from the NIH through collaboration with MindTrace Technologies, Inc. This funding supports the development of an innovative
1
1
11
Nice review by @BryanDChoi and team @MassGeneralNews
nature.com
npj Precision Oncology - CAR-T cell therapy for the treatment of adult high-grade gliomas
1
6
18
Congrats @LGKRichardson @MGHNeurosurg for his talk and on receiving the Molecular Pathology Award at #SNO2024 @NeuroOnc !
2
4
40
@BryanDChoi @NeuroOnc #sno2024 #sno24 on cellular engineered therapy @MassGeneralNews @wenyalindabi @BWHNeurosurgery @BettyKimLab @MDAndersonNews @rupa_juthaniMD @nyulangone @IsaacYangMD @UCLANsgy @UCLAHealth @HarborUCLA @HarborUCLASurg
1
5
14
Significant responses to GD2 CAR T cells in multiple patients with diffuse midline glioma, reported by our colleagues @Stanford in @Nature today. Congrats @michelle_monje and co-authors for this giant leap forward in our field! https://t.co/RtIsgmqy5a
5
16
125
Worlds collide @PennNSG #grandrounds. #GBM #CAR-T expert @BryanDChoi of @MGHNeurosurg joins Penn’s @DrORourke2. + @carlhjune @NdukaAmankulor @DSilverbush @Dr_CJackson @StephenBagleyMD @StevenBremMD 🔥
2
6
49
For this week's #Neurosurgery Grand Rounds, we're excited to have @BryanDChoi with us from @MGHNeurosurg!
0
7
55